
Quirky China trend shows kids, pets hugging giant winter melons to stay cool at night
BEIJING: The scorching summer heat in China has sparked a trend where people hug a giant winter melon while sleeping to find relief from the sweltering temperatures.
The topic 'sleeping with a winter melon is cooler than using an air conditioner' has gone viral on mainland social media, with one Chinese platform alone garnering 4.4 million views.
Many individuals shared photos of themselves slumbering while clutching these large vegetables, which are comparable in size to a toddler, highlighting their remarkable cooling effects.
A resident of northern China's Tianjin municipality, known as Longma, claimed to be among the first to introduce this effective cooling method that ignited the trend.
She purchased a 14kg winter melon from the local market for her child, who complained that the summer heat was making it difficult for him to sleep at night.
Longma noted that she refrained from using air conditioning in the bedrooms to avoid catching a cold, and saw the 'ancient method' of hugging a winter melon as a viable alternative.
Each day, she would gently pat the vegetable to monitor its condition, stating that her winter melon remained in excellent shape after 26 days.
Many families have purchased these vegetables for their children and pets, with photos capturing them snugly clinging to the melons during their sleep. - Photo: RedNote
Another participant from eastern China's Anhui province admitted she felt foolish purchasing a 21kg winter melon at the market, but was pleasantly surprised to discover it was indeed effective.
She mentioned that by keeping the white wax on the melons, they can remain fresh longer.
Numerous people have bought these vegetables for their children and pets. Judging by how tightly they cling to the melons while asleep in the videos, it seems to provide significant benefits.
This method is also quite economical. One individual reported that her 14kg winter melon cost only 54 yuan (US$7.5).
Many have noted they could use the same melon for several days. However, one person cautioned against eating the melon, stating: 'The one people have slept with does not taste good.'
It is said that sleeping while hugging a winter melon is an ancient Chinese remedy for cooling down in the summer.
The vegetable contains over 95 per cent water, which aids in absorbing heat through skin contact.
Traditional Chinese medicine (TCM) also incorporates the vegetable's rind in prescriptions aimed at clearing heat from the body.
TCM expert Yang Zufu from the China Recovery Research Centre explained to People's Daily that this method can benefit those unable to use air conditioning, including the elderly, toddlers, and pregnant women.
However, individuals with weak spleens and stomachs are advised against pressing their bellies against the vegetable for extended periods, as it may exacerbate symptoms like stomach pain or diarrhoea.
Yang recommended that those with sensitivities wrap the melons in towels and position them at a slight distance to minimise side effects.
'Watermelon is also effective, but they're too delicious to resist,' one commenter remarked.
'It stops being funny when you try sleeping with one – it's really useful!' another noted.
A third chimed in: 'So that's why they named it winter melon – to bring some winter to the summer.' - South China Morning Post

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Sun
an hour ago
- The Sun
Shanghai Healthcare M&A Fund Takes Strategic Stake in MicroPort Scientific Corporation
HONG KONG SAR - Media OutReach Newswire - 25 July 2025 – MicroPort Scientific Corporation (Stock Code: 'MicroPort') announced that Shanghai Healthcare M&A Fund ('SHMAF'), a fund managed by SIIC Capital, a subsidiary of SIIC Group, has entered into a share purchase agreement to acquire 135,335,204 shares in MicroPort held by Otsuka Medical Devices Co., Ltd. Through this transaction, SHMAF will become a strategic shareholder in MicroPort, underscoring its role as a state-backed, professionally operated platform that is creating value and empowering, stabilizing, developing, and reshaping leading biopharmaceutical companies in China. As a homegrown Chinese innovator that has grown into a global leader in high-end medical devices, MicroPort serves as an anchor company for the industry. Its stable development is critical to both China's and the global high-end medical device supply chain. This investment reflects SHMAF's capital-driven approach to providing crucial support to domestic anchor companies, ensuring their stability and support growth of their core assets. SHMAF will support MicroPort's growth momentum and high-quality sustainable development with its expansive resources. Introducing a strategic shareholder to drive growth momentum. The transaction brings in a significant strategic shareholder for MicroPort. Leveraging its state-backed resources and industrial expertise, SHMAF will support MicroPort's development needs, core business expansion, and potential strategic mergers and acquisitions to create synergies that bolster the company's ongoing innovation and scale-up its operations. Optimizing resource allocation to unlock synergistic value. MicroPort has successfully incubated and nurtured multiple listed companies and specialized, highly influential small companies, in the process establishing a unique MicroPort ecosystem. SHMAF will leverage its capital and operational integration expertise to support MicroPort in refining its development strategy, optimizing resource allocation, and unlocking synergistic value—while fully respecting market dynamics and corporate autonomy—to further strengthen its ecosystem and competitive advantages. Enhancing ecosystem to enhance anchor company value. MicroPort's product portfolio spans across ten major verticals, including cardiovascular intervention, rhythm management, orthopaedics, neurovascular intervention, and surgical robotics, making it a core player in the high-end medical device industrial chain. SHMAF's support will not only drive MicroPort's growth, it will also accelerate its consolidation of upstream and downstream companies in Shanghai, attract highly-skilled talent, and facilitate breakthroughs in critical technologies and core components—ultimately enhancing the global competitiveness of China's high-end medical device industry. This transaction marks another significant step in SHMAF's commitment to serving biopharmaceutical anchor companies. Upholding its value investment principles, SHMAF will collaborate with MicroPort's shareholders and management team to leverage the strategic support and industrial synergies its state-backed platform offers. Together, they will reinforce MicroPort's position as China's innovation engine in high-end medical devices and contribute to the advancement of the biopharmaceutical industry.


Malaysia Sun
19 hours ago
- Malaysia Sun
$10mn of USAID contraceptives to be burned in France media
The shipment destined for poor nations ended up stuck in Europe due to the shutdown of the agency A $10 million shipment of US-funded contraceptives will be incinerated in France, after Washington rejected offers to send the supplies to poorer nations, Reuters reported on Wednesday. The stockpile - made up of birth control pills and implants - has been stuck in Belgium since early 2025, when President Donald Trump shut down USAID and froze foreign aid programs. The supplies were originally meant for distribution in developing countries. A State Department spokesperson confirmed the destruction plan, saying the disposal will cost around $167,000 and take place at a medical waste facility in France. The contraceptives are being stored in the city of Geel and will require dozens of truckloads and at least two weeks to move, sources told Reuters. Belgian authorities have attempted to prevent the destruction of the supplies yet ultimately failed to do so, having exhausted "all possible options to prevent the destruction, including temporary relocation." "Despite these efforts, and with full respect for our partners, no viable alternative could be secured. Nevertheless, Belgium continues to actively seek solutions to avoid this regrettable outcome," the country's Foreign Ministry said in a statement, adding that "sexual and reproductive health must not be subject to ideological constraints." Human rights groups that attempted to buy the supplies from Washington have also suggested the impending destruction is being driven by "ideological" motives rather than a desire to cut costs. Sarah Shaw, Associate Director of Advocacy at MSI Reproductive Choices, told Reuters the NGO approached Washington with an offer to pay for repackaging of the supplies without USAID branding and for shipment to their destinations, but the proposal was declined. "MSI offered to pay for repackaging, shipping, and import duties, but they were not open to that... We were told that the US government would only sell the supplies at the full market value," said Shaw. "This is clearly not about saving money. It feels more like an ideological assault on reproductive rights, and one that is already harming women," she added. The UN sexual and reproductive health agency, UNFPA, also reportedly offered to buy the shipment. The talks ultimately broke down, partially due to a lack of response from the US government, a source with direct knowledge told Reuters. (


The Star
a day ago
- The Star
China reports record wave of mosquito-borne chikungunya virus
Guangdong province has launched stricter anti-mosquito measures, including urging residents to clear stagnant water. -- PHOTO: UNSPLASH via The Straits Times/ANN BEIJING (Bloomberg): A city in China's southern industrial hub has recorded 3,195 chikungunya cases so far this month, the country's biggest outbreak of the mosquito-borne virus since it first emerged in the mainland nearly two decades ago. Foshan city - in Guangdong Province, just north of Hong Kong - first reported an imported chikungunya case earlier in July, China's national broadcaster CCTV said, citing briefings from local authorities. Infections have soared by more than 2,700 in the past week alone. While Chinese health officials have yet to explain what's behind the outbreak, Guangdong has launched stricter anti-mosquito measures, including urging residents to clear stagnant water and make sure drainage channels remain unobstructed. Chikungunya, first identified in 1952 in Tanzania, is transmitted to humans by infected mosquitoes, the World Health Organization says. The virus causes fever and severe joint pain, and other symptoms can include headaches, muscle pain, vomiting and fatigue. The outbreak in Guangdong, an often hot and humid area of southern China, is the latest sign that tropical diseases - from dengue to malaria and zika - are expanding their reach, as climate change lets mosquitoes live in new territories that have become warmer and wetter. Increased international travel and low population immunity are also helping the spread. An explosion in cases in the Indian Ocean since the start of 2025 has sparked concerns of a spread to other countries, leading the WHO to issue an urgent call to action this week, Reuters reported. France and Italy, thousands of miles from the region, have both found locally-acquired chikungunya cases this year. "The surge in chikungunya cases is likely due to favorable climatic conditions that allow blooms of the Aedes mosquito population,' said Robert Jones, Assistant Professor in the Department of Disease Control at the London School of Hygiene & Tropical Medicine. "These are aggressive, day-biting mosquitoes that thrive in warm, wet conditions.' More than five billion people live in areas across 119 countries at risk from chikungunya, the WHO told reporters in Geneva, Reuters said. Some 220,000 cases and 80 related deaths have been reported in 14 countries and territories globally so far this year, according to the European Centre for Disease Prevention and Control. China recorded its first chikungunya case in 2008, an imported infection detected at an airport in Guangdong. The first locally transmitted cases - infecting 253 people - were reported in the province two years later. Since then, only sporadic cases have been found, in Yunnan and Fujian provinces. Globally, population susceptibility is likely elevated in areas where chikungunya outbreaks haven't tended to occur, said Patricia Gallego Delgado, Associate Director at London-based disease forecasting firm Airfinity Ltd. The wave is "attributable to lower levels of population immunity as individuals in these regions may have had limited or no prior exposure to the virus,' she said. -- ©2025 Bloomberg L.P.